Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain
暂无分享,去创建一个
Mauno Vihinen | Liang Yu | Alar Aints | M. Vihinen | C. I. Smith | A. Aints | B. Christensson | A. J. Mohamed | Abdalla J. Mohamed | Carl‐Magnus Bäckesjö | Leonardo Vargas | Rani Faryal | Birger Christensson | Anna Berglöf | Beston F. Nore | C. I. Edvard Smith | L. Vargas | A. Berglöf | B. Nore | C. Bäckesjö | R. Faryal | Li’ang Yu | C. E. Edvard Smith | C. Bäckesjö
[1] M. Vihinen,et al. BTKbase: the mutation database for X‐linked agammaglobulinemia , 2006, Human mutation.
[2] C. Feighery,et al. Signaling by Toll-like Receptors 8 and 9 Requires Bruton's Tyrosine Kinase* , 2007, Journal of Biological Chemistry.
[3] A. Tarakhovsky,et al. PKCβ modulates antigen receptor signaling via regulation of Btk membrane localization , 2001, The EMBO journal.
[4] T. Wirth,et al. Bruton's Tyrosine Kinase Is a Toll/Interleukin-1 Receptor Domain-binding Protein That Participates in Nuclear Factor κB Activation by Toll-like Receptor 4* , 2003, Journal of Biological Chemistry.
[5] C. I. Smith,et al. Functional Interaction of Caveolin-1 with Bruton's Tyrosine Kinase and Bmx* , 2002, The Journal of Biological Chemistry.
[6] D. Baltimore,et al. Proline-rich sequences that bind to Src homology 3 domains with individual specificities. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Sowadski,et al. Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[8] N. Tanaka,et al. Itk, a T cell-specific tyrosine kinase, is required for CD2-mediated interleukin-2 promoter activation in the human T cell line Jurkat. , 1997, European journal of immunology.
[9] T. Yamadori,et al. Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK--functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling. , 1999, Blood.
[10] M. Simon,et al. Binding of beta gamma subunits of heterotrimeric G proteins to the PH domain of Bruton tyrosine kinase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[11] C. I. Smith,et al. The cellular phenotype conditions Btk for cell survival or apoptosis signaling , 2000, Immunological reviews.
[12] J. Rowley,et al. Mimicry of a constitutively active pre–B cell receptor in acute lymphoblastic leukemia cells , 2005, The Journal of experimental medicine.
[13] P. Storz,et al. Bruton's tyrosine kinase (Btk) associates with protein kinase C μ , 1999 .
[14] H. Ochs,et al. Contiguous X-chromosome Deletion Syndrome Encompassing the BTK, TIMM8A, TAF7L, and DRP2 Genes , 2007, Journal of Clinical Immunology.
[15] T. Kurosaki,et al. Differential regulation of NFAT and SRF by the B cell receptor via a PLCgamma-Ca(2+)-dependent pathway. , 2003, The EMBO journal.
[16] A. Kochetov,et al. Alternative translation start sites and hidden coding potential of eukaryotic mRNAs. , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.
[17] Fatih M. Uckun,et al. Transcription Factor STAT5A Is a Substrate of Bruton's Tyrosine Kinase in B Cells* , 2001, The Journal of Biological Chemistry.
[18] C. Kinnon,et al. The SH3 domain of Bruton's tyrosine kinase displays altered ligand binding properties when auto‐phosphorylated in vitro , 1999, European journal of immunology.
[19] Cornelia Brunner,et al. Btk expression is controlled by Oct and BOB.1/OBF.1 , 2006, Nucleic acids research.
[20] T. Rülicke,et al. The transcriptional regulator PLZF induces the development of CD44 high memory phenotype T cells , 2008, Proceedings of the National Academy of Sciences.
[21] J. Kinet,et al. BTK regulates PtdIns-4,5-P2 synthesis: importance for calcium signaling and PI3K activity. , 2003, Immunity.
[22] Jessica M. Lindvall,et al. Expression profiling of chicken DT40 lymphoma cells indicates clonal selection of knockout and gene reconstituted cells. , 2008, Biochemical and biophysical research communications.
[23] Bairong Shen,et al. Genome wide analysis of pathogenic SH2 domain mutations , 2008, Proteins.
[24] Mauno Vihinen,et al. BTKbase, mutation database for X-linked agammaglobulinemia (XLA) , 1996, Nucleic Acids Res..
[25] F. Sotgia,et al. A Novel Role for Caveolin-1 in B Lymphocyte Function and the Development of Thymus-Independent Immune Responses , 2006, Cell cycle.
[26] John D Lambris,et al. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. , 1994, Journal of immunology.
[27] K. Sullivan,et al. Discordant phenotype in siblings with X-linked agammaglobulinemia. , 1996, American journal of human genetics.
[28] M. Vihinen,et al. KinMutBase: A registry of disease‐causing mutations in protein kinase domains , 2005, Human mutation.
[29] A. M. Riley,et al. Structure of the PH domain from Bruton's tyrosine kinase in complex with inositol 1,3,4,5-tetrakisphosphate. , 1999, Structure.
[30] F. Uckun,et al. Defective Expression of Bruton's Tyrosine Kinase in Acute Lymphoblastic Leukemia , 2003, Leukemia & lymphoma.
[31] A. Satterthwaite,et al. Constitutive membrane association potentiates activation of Bruton tyrosine kinase , 1997, Oncogene.
[32] M. Conley,et al. Mutations in btk in patients with presumed X-linked agammaglobulinemia. , 1998, American journal of human genetics.
[33] S. Philipsen,et al. Synergistic activation of the human Btk promoter by transcription factors Sp1/3 and PU.1. , 1999, Biochemical and biophysical research communications.
[34] M. Vihinen,et al. The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.
[35] A. Veillette,et al. Differential Intrinsic Enzymatic Activity of Syk and Zap-70 Protein-tyrosine Kinases* , 1996, The Journal of Biological Chemistry.
[36] I. Weissman,et al. Posttranscriptional regulation of Bruton's tyrosine kinase expression in antigen receptor-stimulated splenic B cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[37] Seng-Lai Tan,et al. Selective role of PKCbeta enzymatic function in regulating cell survival mediated by B cell antigen receptor cross-linking. , 2006, Immunology letters.
[38] Taiji Ito,et al. Bruton's tyrosine kinase (Btk) enhances transcriptional co-activation activity of BAM11, a Btk-associated molecule of a subunit of SWI/SNF complexes. , 2004, International immunology.
[39] M. Reth,et al. Bruton's Tyrosine Kinase Cooperates with the B Cell Linker Protein SLP-65 as a Tumor Suppressor in Pre-B Cells , 2003, The Journal of experimental medicine.
[40] R. Rabin,et al. Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein , 2001, Nature Immunology.
[41] Jessica M. Lindvall,et al. Defective Toll‐like receptor 9‐mediated cytokine production in B cells from Bruton's tyrosine kinase‐deficient mice , 2007, Immunology.
[42] T. Yamadori,et al. Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[43] F. Uckun,et al. Bruton's tyrosine kinase (BTK) as a dual-function regulator of apoptosis. , 1998, Biochemical pharmacology.
[44] Liang Yu,et al. Proteasome-dependent autoregulation of Bruton tyrosine kinase (Btk) promoter via NF-kappaB. , 2008, Blood.
[45] K. Lu,et al. Regulation of Bruton Tyrosine Kinase by the Peptidylprolyl Isomerase Pin1* , 2006, Journal of Biological Chemistry.
[46] P. Schwartzberg,et al. Tec kinases, actin, and cell adhesion , 2007, Immunological reviews.
[47] C. Jefferies,et al. MyD88 Adapter-like (Mal) Is Phosphorylated by Bruton's Tyrosine Kinase during TLR2 and TLR4 Signal Transduction* , 2006, Journal of Biological Chemistry.
[48] G. Superti-Furga,et al. Phosphorylation of Bruton's tyrosine kinase by c-Abl. , 2002, Biochemical and biophysical research communications.
[49] R. Woodland,et al. BCR Engagement Induces Fas Resistance in Primary B Cells in the Absence of Functional Bruton’s Tyrosine Kinase1 , 2002, The Journal of Immunology.
[50] M Vihinen,et al. Mutations of the human BTK gene coding for bruton tyrosine kinase in X‐linked agammaglobulinemia , 1999, Human mutation.
[51] Yun Jiang,et al. The G protein Gα12 stimulates Bruton's tyrosine kinase and a rasGAP through a conserved PH/BM domain , 1998, Nature.
[52] J. Kehrl,et al. Analysis of the Bruton's tyrosine kinase gene promoter reveals critical PU.1 and SP1 sites. , 1996, Blood.
[53] P. Schwartzberg,et al. Altered development of CD8+ T cell lineages in mice deficient for the Tec kinases Itk and Rlk. , 2006, Immunity.
[54] R. Hendriks,et al. Tumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity. , 2005, Blood.
[55] T. Kunikata,et al. Identification and characterization of a novel SH3-domain binding protein, Sab, which preferentially associates with Bruton's tyrosine kinase (BtK). , 1998, Biochemical and biophysical research communications.
[56] H. Ochs,et al. X-linked agammaglobulinemia. A clinical and molecular analysis. , 1996, Medicine.
[57] A. Tarakhovsky,et al. Immunodeficiency in Protein Kinase Cβ-Deficient Mice , 1996, Science.
[58] G. Bourikas,et al. Absence of Bruton's tyrosine kinase (Btk) mutations in patients with acute myeloid leukaemia , 1998, British journal of haematology.
[59] L. Honigberg,et al. Bruton's tyrosine kinase is not essential for Bcr-Abl-mediated transformation of lymphoid or myeloid cells , 2008, Leukemia.
[60] T. Kurosaki,et al. BTK as a Mediator of Radiation-Induced Apoptosis in DT-40 Lymphoma B Cells , 1996, Science.
[61] C. I. Smith,et al. Molecular and cellular aspects of X-linked agammaglobulinemia. , 1995, Advances in immunology.
[62] D. Littman,et al. Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. , 1995, Immunity.
[63] F. Grosveld,et al. Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre‐B cell stage. , 1996, The EMBO journal.
[64] M. Saraste,et al. Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X‐linked agammaglobulinaemia , 1997, The EMBO journal.
[65] M. Simonetta,et al. Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton's tyrosine kinase: evidence for three protein isoforms of IBtk , 2008, Nucleic acids research.
[66] S. Desiderio,et al. Identification of Phosphorylation Sites for Bruton's Tyrosine Kinase within the Transcriptional Regulator BAP/TFII-I* , 2001, The Journal of Biological Chemistry.
[67] Jessica M. Lindvall,et al. Distinct gene expression signature in Btk-defective T1 B-cells. , 2006, Biochemical and biophysical research communications.
[68] M. Vihinen,et al. Missense mutations affecting a conserved cysteine pair in the TH domain of Btk , 1997, FEBS letters.
[69] G. Martin,et al. The road to Src , 2004, Oncogene.
[70] C. Kevil,et al. Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. , 1995, Oncogene.
[71] T. Wirth,et al. Bruton's Tyrosine Kinase is involved in innate and adaptive immunity. , 2005, Histology and histopathology.
[72] Xiao Zhen Zhou,et al. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease , 2007, Nature Reviews Molecular Cell Biology.
[73] Kendall W. Cradic,et al. Competing modes of self‐association in the regulatory domains of Bruton's tyrosine kinase: Intramolecular contact versus asymmetric homodimerization , 2002, Protein science : a publication of the Protein Society.
[74] T. Kurosaki,et al. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2 , 1996, The Journal of experimental medicine.
[75] R. Sen,et al. Bruton's Tyrosine Kinase Links the B Cell Receptor to Nuclear Factor κb Activation , 2000, The Journal of experimental medicine.
[76] C. Webb,et al. The Transcription Factor Bright Associates with Bruton’s Tyrosine Kinase, the Defective Protein in Immunodeficiency Disease1 , 2000, The Journal of Immunology.
[77] P. Várnai,et al. Phosphatidylinositol 3-Kinase-dependent Membrane Association of the Bruton’s Tyrosine Kinase Pleckstrin Homology Domain Visualized in Single Living Cells* , 1999, The Journal of Biological Chemistry.
[78] P. Schwartzberg,et al. Tec family kinases in T lymphocyte development and function. , 2005, Annual review of immunology.
[79] O. Jean-Jean,et al. Translation of the hepatitis B virus P gene by ribosomal scanning as an alternative to internal initiation , 1993, Journal of virology.
[80] M. Hirano,et al. Identification and characterization of a molecule, BAM11, that associates with the pleckstrin homology domain of mouse Btk. , 2000, International immunology.
[81] M. Vihinen,et al. Intermolecular interactions between the SH3 domain and the proline‐rich TH region of Bruton's tyrosine kinase , 2001, FEBS letters.
[82] T. Kodama,et al. Tyrosine Kinases Btk and Tec Regulate Osteoclast Differentiation by Linking RANK and ITAM Signals , 2008, Cell.
[83] S. Pillai,et al. Regulation of Nuclear Localization and Transcriptional Activity of TFII-I by Bruton’s Tyrosine Kinase , 1999, Molecular and Cellular Biology.
[84] L. Berg,et al. The Tec Kinases Itk and Rlk Regulate NKT Cell Maturation, Cytokine Production, and Survival1 , 2008, The Journal of Immunology.
[85] A. Poole,et al. Interaction of Bruton's tyrosine kinase and protein kinase Ctheta in platelets. Cross-talk between tyrosine and serine/threonine kinases. , 2002, The Journal of biological chemistry.
[86] P. Chavrier,et al. Tyrosine phosphorylation of the Wiskott‐Aldrich Syndrome protein by Lyn and Btk is regulated by CDC42 , 1998, FEBS letters.
[87] M. Vihinen,et al. Structural basis of SH2 domain mutations in X-linked agammaglobulinemia. , 1994, Biochemical and biophysical research communications.
[88] A. Satterthwaite,et al. Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain. , 1995, Immunity.
[89] Jessica Lindvall,et al. Expression profiling in transformed human B cells: influence of Btk mutations and comparison to B cell lymphomas using filter and oligonucleotide arrays , 2002, European journal of immunology.
[90] R. Guinamard,et al. The SH3 Domain of Bruton's Tyrosine Kinase Interacts with Vav, Sam68 and EWS , 1997, Scandinavian journal of immunology.
[91] T. Kurosaki,et al. Differential regulation of NFAT and SRF by the B cell receptor via a PLCγ–Ca2+‐dependent pathway , 2003 .
[92] Paul J Hertzog,et al. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation , 2006, Nature Immunology.
[93] Steffen Jung,et al. Severe B Cell Deficiency in Mice Lacking the Tec Kinase Family Members Tec and Btk , 2000, The Journal of experimental medicine.
[94] D. Vetrie,et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases , 1993, Nature.
[95] X. Huang,et al. Identification of the binding site for Gqalpha on its effector Bruton's tyrosine kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[96] H. Mellor,et al. The novel Rho-family GTPase Rif regulates coordinated actin-based membrane rearrangements , 2000, Current Biology.
[97] D. Yamamoto,et al. Functional replacement of Drosophila Btk29A with human Btk in male genital development and survival , 2005, FEBS Letters.
[98] Jessica M. Lindvall,et al. Differential expression and molecular characterisation of Lmo7, Myo1e, Sash1, and Mcoln2 genes in Btk-defective B-cells. , 2005, Cellular immunology.
[99] T. Kawakami,et al. A role for PKCtheta in outside-in alpha(IIb)beta3 signaling. , 2006, Journal of thrombosis and haemostasis : JTH.
[100] J. Rowley,et al. Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[101] Anna Westlund,et al. Conformation of full‐length Bruton tyrosine kinase (Btk) from synchrotron X‐ray solution scattering , 2003, The EMBO journal.
[102] A. Weiss,et al. Expression and Function of Tec, Itk, and Btk in Lymphocytes: Evidence for a Unique Role for Tec , 2004, Molecular and Cellular Biology.
[103] H. Varmus,et al. Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. , 1999, Science.
[104] C. I. Smith,et al. Redistribution of Bruton's tyrosine kinase by activation of phosphatidylinositol 3‐kinase and Rho‐family GTPases , 2000, European journal of immunology.
[105] H. Ochs,et al. Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B‐cell receptor activation , 1998, The EMBO journal.
[106] P. Janmey,et al. Pleckstrin Homology Domains Interact with Filamentous Actin* , 1999, The Journal of Biological Chemistry.
[107] M. Vihinen,et al. Phylogeny of Tec family kinases identification of a premetazoan origin of Btk, Bmx, Itk, Tec, Txk, and the Btk regulator SH3BP5. , 2008, Advances in genetics.
[108] C. Webb,et al. Induction of Immunoglobulin Heavy-Chain Transcription through the Transcription Factor Bright Requires TFII-I , 2006, Molecular and Cellular Biology.
[109] S. Yokoyama,et al. Crystal structure of the Bruton's tyrosine kinase PH domain with phosphatidylinositol. , 2008, Biochemical and biophysical research communications.
[110] C. I. Smith,et al. Cell specific expression of human Bruton's agammaglobulinemia tyrosine kinase gene (Btk) is regulated by Sp1- and Spi-1/PU.1-family members. , 1996, Oncogene.
[111] T. Wirth,et al. Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. , 2003, The Journal of biological chemistry.
[112] R. Sinke,et al. Multiple colorectal neoplasms in X-linked agammaglobulinemia. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[113] T. Kawakami,et al. The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[114] Jessica M. Lindvall,et al. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling , 2005, Immunological reviews.
[115] C. I. Smith,et al. Gene expression signatures in primary immunodeficiencies: the experience from human disease and mouse models. , 2007, Current molecular medicine.
[116] F. Alt,et al. Defective B cell development and function in Btk-deficient mice. , 1995, Immunity.
[117] M. Cybulsky,et al. Dual Functions of Bruton’s Tyrosine Kinase and Tec Kinase during Fcγ Receptor-Induced Signaling and Phagocytosis1 , 2008, The Journal of Immunology.
[118] D J Rawlings,et al. Regulation of Btk function by a major autophosphorylation site within the SH3 domain. , 1996, Immunity.
[119] E. Wong,et al. Bruton's Tyrosine Kinase Separately Regulates NFκB p65RelA Activation and Cytokine Interleukin (IL)-10/IL-12 Production in TLR9-stimulated B Cells* , 2008, Journal of Biological Chemistry.
[120] P. Schwartzberg,et al. Tec kinases: modulators of lymphocyte signaling and development. , 2001, Current opinion in immunology.
[121] W. Khan,et al. Bruton's Tyrosine Kinase Is Required for Activation of Iκb Kinase and Nuclear Factor κb in Response to B Cell Receptor Engagement , 2000, The Journal of experimental medicine.
[122] M. Potter,et al. BALB/c.CBA/N mice carrying the defective Btk(xid) gene are resistant to pristane-induced plasmacytomagenesis. , 1999, International immunology.
[123] D. Rawlings,et al. Tec Kinases Mediate Sustained Calcium Influx via Site-specific Tyrosine Phosphorylation of the Phospholipase Cγ Src Homology 2-Src Homology 3 Linker* , 2004, Journal of Biological Chemistry.
[124] L. Foroni,et al. Acaps Are Arf6 Gtpase-Activating Proteins That Function in the Cell Periphery , 2000, The Journal of cell biology.
[125] Jessica M. Lindvall,et al. Gene expression profile of B cells from Xid mice and Btk knockout mice , 2004, European journal of immunology.
[126] J. D. Thomas,et al. Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci. , 1994, Journal of immunology.
[127] P. Storz,et al. Bruton's tyrosine kinase (Btk) associates with protein kinase C mu. , 1999, FEBS letters.
[128] Roger L. Williams,et al. Tyrosine Residues in Phospholipase Cγ2 Essential for the Enzyme Function in B-cell Signaling* , 2001, The Journal of Biological Chemistry.
[129] S. Tzeng,et al. SH3 domain of Bruton's tyrosine kinase can bind to proline‐rich peptides of TH domain of the kinase and p120cbl , 1997, Proteins.
[130] A. Sher,et al. Mutation of Tec family kinases alters T helper cell differentiation , 2001, Nature Immunology.
[131] M. Ji,et al. Id2 intrinsically regulates lymphoid and erythroid development via interaction with different target proteins. , 2008, Blood.
[132] F. Grosveld,et al. Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase , 1998, The EMBO journal.
[133] T. Behrens,et al. PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction , 2003, Nature Immunology.
[134] A. Andreotti,et al. Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk. , 2004, Immunity.
[135] S. Desiderio,et al. BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[136] H. Mano,et al. A novel protein-tyrosine kinase, tec, is preferentially expressed in liver. , 1990, Oncogene.
[137] M. Zvelebil,et al. Structural basis for pleckstrin homology domain mutations in X-linked agammaglobulinemia. , 1995, Biochemistry.
[138] R. Berland,et al. Normal B-1a cell development requires B cell-intrinsic NFATc1 activity , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[139] J. Bluestone,et al. Identification of Rlk, a Novel Protein Tyrosine Kinase with Predominant Expression in the T Cell Lineage (*) , 1995, The Journal of Biological Chemistry.
[140] F. Alt,et al. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. , 1999, Science.
[141] A. Roy,et al. Mechanism of Bruton's Tyrosine Kinase-mediated Recruitment and Regulation of TFII-I* , 2004, Journal of Biological Chemistry.
[142] S. Watson,et al. A role for Bruton's tyrosine kinase (Btk) in platelet activation by collagen , 1998, Current Biology.
[143] T. Kurosaki,et al. BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. , 2000, Immunity.
[144] Taesoo Kim,et al. The Tec Family Tyrosine Kinase Btk Regulates RANKL-induced Osteoclast Maturation* , 2008, Journal of Biological Chemistry.
[145] A. Tarakhovsky,et al. Immunodeficiency in protein kinase cbeta-deficient mice. , 1996, Science.
[146] P. Schwartzberg,et al. Tec kinases: shaping T-cell activation through actin. , 2004, Trends in cell biology.
[147] W. Paul,et al. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. , 1993, Science.
[148] K. Alitalo,et al. The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner , 2000, Oncogene.
[149] K. Alitalo,et al. Essential Roles for the Tec Family Kinases Tec and Btk in M-CSF Receptor Signaling Pathways That Regulate Macrophage Survival1 , 2008, The Journal of Immunology.
[150] Mauno Vihinen,et al. BTKbase, mutation database for X-linked agammaglobulinemia (XLA) , 1998, Nucleic Acids Res..
[151] G Fischer,et al. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. , 2000, Molecular cell.
[152] C. Webb,et al. Bruton's Tyrosine Kinase Regulates Immunoglobulin Promoter Activation in Association with the Transcription Factor Bright , 2005, Molecular and Cellular Biology.
[153] B. Christensson,et al. Nucleocytoplasmic Shuttling of Bruton's Tyrosine Kinase* , 2000, The Journal of Biological Chemistry.
[154] L. Berg,et al. Tec kinases in T cell and mast cell signaling. , 2007, Advances in immunology.
[155] S. Hartman,et al. Regulation of protein kinase CbetaI by two protein-tyrosine kinases, Btk and Syk. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[156] I. Vořechovský,et al. X‐Linked Agammaglobulinemia and Other Immunoglobulin Deficiencies , 1994, Immunological reviews.
[157] T. Kawakami,et al. A role for PKCθ in outside‐in αIIbβ3 signaling , 2006 .
[158] Fatih M. Uckun,et al. Bruton’s Tyrosine Kinase as an Inhibitor of the Fas/CD95 Death-inducing Signaling Complex* , 1999, The Journal of Biological Chemistry.
[159] C. Cunningham-Rundles,et al. X-Linked Agammaglobulinemia: Report on a United States Registry of 201 Patients , 2006, Medicine.
[160] M. Vihinen,et al. Tec homology (TH) adjacent to the PH domain , 1994, FEBS letters.
[161] A. Andreotti,et al. A specific intermolecular association between the regulatory domains of a Tec family kinase. , 2000, Journal of molecular biology.
[162] W. Ellmeier,et al. The Role of Tec Family Kinases in Myeloid Cells , 2004, International Archives of Allergy and Immunology.
[163] Ornella Parolini,et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia , 1993, Cell.